Portland Global Advisors LLC Gilead Sciences, Inc. Transaction History

Portland Global Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$56.65 - $64.55 $197,028 - $224,504	-3,478 Closed	0 $0
Q2 2020 Jul 23, 2020	SELL	$72.34 - $84.0 $36,170 - $42,000	-500 Reduced 12.57%	3,478 $268,000
Q2 2019 Jul 26, 2019	SELL	$61.87 - $69.38 $30,935 - $34,690	-500 Reduced 11.17%	3,978 $269,000
Q4 2018 Jan 23, 2019	SELL	$60.54 - $79.0 $12,108 - $15,800	-200 Reduced 4.28%	4,478 $280,000
Q3 2018 Oct 23, 2018	SELL	$71.28 - $78.92 $242,352 - $268,328	-3,400 Reduced 42.09%	4,678 $361,000
Q2 2018 Jul 31, 2018	SELL	$64.88 - $75.68 $188,152 - $219,472	-2,900 Reduced 26.42%	8,078 $572,000
Q1 2018 May 04, 2018	BUY	$72.84 - $88.8 $546,300 - $666,000	7,500 Added 215.64%	10,978 $828,000
Q3 2017 Nov 01, 2017	BUY	$72.11 - $85.47 $250,798 - $297,264	3,478	3,478 $282,000

1,926

992M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Portland Global Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Portland Global Advisors LLC with notifications on news.